DOCSLIB.ORG

Menthol-Modified BSA Nanoparticles for Glioma Targeting Therapy Using

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Menthol-Modified BSA Nanoparticles for Glioma Targeting Therapy Using Liang et al. NPG Asia Materials (2019) 11:38 https://doi.org/10.1038/s41427-019-0138-6 NPG Asia Materials ARTICLE Open Access Menthol-modified BSA nanoparticles for glioma targeting therapy using an energy restriction strategy Jianming Liang1,2,3,YingZhu2,CaifangGao1,3, Chengli Ling4, Jing Qin1,QiWang5, Yongzhuo Huang6,WeigenLu3 and Jianxin Wang 1,5 Abstract Current chemotherapeutics for glioma are not sufficiently effective due to their low tolerance and poor blood–brain barrier (BBB) permeability. Energy restriction based on co-delivery of albendazole (Abz) and nano-silver has been proven to suppress tumor growth without adverse effects. Accordingly, menthol was conjugated to BSA (MeB) to overcome the BBB-permeability issue. In this study, Abz-loaded MeB-silver nanoparticles (MBS-Abz) were developed by self-assembly of MeB, albendazole and nano silver for glioma targeting therapy. The nanoparticle entered the brain across the BBB and specifically accumulated in the glioma region. MeB delivered the nanoparticles across the brain capillary endothelial cell monolayer by promoting internalization and BBB disruption. MBS-Abz hindered ATP generation via the inhibition of glycolytic and mitochondrial pathways both in vitro and in vivo. The anti-glioma mechanisms of energy restriction were related to the cytotoxicity, proliferation inhibition, cell cycle arrest, and apoptosis induced by ATP exhaustion, and the effects of MBS-Abz were significantly better than those induced by monotherapy nanoparticles or unmodified nanoparticles. These results demonstrated that by combining the energy 1234567890():,; 1234567890():,; 1234567890():,; 1234567890():,; restriction effect of albendazole and nano silver, as well as the BBB penetration ability of menthol, MBS-Abz achieves superior anti-glioma efficacy and can be an effective strategy for glioma therapy. Introduction nitrosoureas and platinum-based drugs, can curb the Cancer has replaced cardiovascular disease as the growth of glioma cells, they also cause serious adverse leading cause of death in the United States1. Although effects, such as nephrotoxicity by cisplatin and pulmonary many antitumor drugs have been developed, the global toxicity by nitrosoureas3,4, which lead to poor tolerance burden of cancer is still high. Brain cancers account for and limited efficacy5. Therefore, the need to develop safe approximately 3% of the global cancer cases2, among and effective strategies for glioma treatment is pressing. which, gliomas are associated with high morbidity and Since tumor cells proliferate rapidly and infinitely6, they mortality. Chemotherapy is a major therapeutic modality consume substantial amounts of energy to maintain this for glioma. Although cytotoxic agents, such as abnormal growth process7. Abnormal energy metabolism is an important physiological characteristic of glioma8,9. Adenosine triphosphate (ATP) is the most direct source Correspondence: Yongzhuo Huang ([email protected])or of energy, and compared with normal cells, glioma cells Weigen Lu ([email protected]) or Jianxin Wang ([email protected]) 10 1 are more sensitive to ATP levels . Energy restriction was Department of Pharmaceutics, School of Pharmacy, Fudan University & Key 11,12 Laboratory of Smart Drug Delivery, Ministry of Education, 201203 Shanghai, PR confirmed to effectively inhibit glioma growth . Thus, China energy metabolism inhibition may be an effective 2 Institute of Tropical Medicine, Guangzhou University of Chinese Medicine, approach for glioma therapy. Glioma cells mainly gen- 510006 Guangzhou, PR China Full list of author information is available at the end of the article. erate ATP via the glycolytic pathway rather than oxidative These authors contributed equally: Jianming Liang, Ying Zhu © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a linktotheCreativeCommons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. Liang et al. NPG Asia Materials (2019) 11:38 Page 2 of 18 phosphorylation, which is known as the Warburg effect. systems, the most commonly used method, may enhance The inhibition of glycolytic enzyme activities can effec- brain penetration34, there are still some limitations. First, tively decrease ATP production and cell proliferation13. while it is very likely that the aromatic resuscitation When glycolysis is inhibited, tumor cells compensatively components reach the BBB, the nano-carriers may still increase ATP synthesis via the mitochondrial pathway to circulate in other parts of the body, making it difficult for meet the need for physiological functions14, which ren- the active substance to pass the BBB and reach the brain ders the curative effect of monotherapy (glycolysis inhi- tumor site. Second, the physical mixture of BPEs and drug bitor only) unsatisfactory15. Therefore, ideal energy delivery systems may open the BBB for too long, causing inhibition should block ATP synthase by simultaneously the entrance of harmful substances into the brain and inhibiting the glycolytic and mitochondrial pathways. In possible damage to the brain tissue. Third, because the our previous study, we developed a novel antitumor delivery efficiency of simple mixing is very low, a higher strategy based on energy restriction by utilizing albenda- dose of aromatic resuscitation components might be zole (Abz) and silver nanoparticles (SNP) as glycolysis required, which might cause severe damage to the blood inhibitors and mitochondrial inhibitors, respectively16. vessels and other organs31. Chemical coupling could be an Abz inhibits glycolytic enzyme activities and down- effective method35,36 to overcome these shortcomings by regulates hypoxia-inducible factor I expression, thus synchronizing delivery of aromatic resuscitation compo- inhibiting glycolysis17,18. Moreover, Abz nanoparticles nents and nanoparticles at the BBB, and potentially efficiently suppressed the growth of solid tumors19, and enhancing the water solubility of BPEs. Menthol, the main Abz decreased tumor markers, in addition to being well active component of corn mint, is one of the most widely tolerated in a phase I clinical trial20. SNP reduced mito- used aromatic resuscitation drugs in traditional Chinese chondrial function and inhibited ATP generation via the medicine. This molecule enhances the penetration of mitochondrial pathway21,22. Therefore, our strategy based many drugs into the brain by downregulating the level of on the combination of Abz and SNP was expected to TJ proteins37,38. effectively and safely restrict glioma growth, even though Penetration of the brain tissue across the BBB is not no cytotoxic antitumor agent was used during the sufficient, as the nanoparticles need to accumulate in treatment. satisfactory concentrations in the glioma region. Tumor The delivery of therapeutic agents is more difficult in cells need a substantial amount of nutrients, such as glioma than in other tumors because of the blood–brain albumin, for rapid proliferation39. Specifically, glioma cells barrier (BBB). The BBB is a continuous endothelial up-regulate the expression of albumin-binding protein monolayer coupled by tight junctions (TJs), with extre- and secreted protein acidic and rich in cysteine (SPARC) mely low permeability for the exchange of materials23. For to uptake albumin40,41. However, SPARC-albumin bind- brain targeting, drug-delivery strategies, such as receptor- ing has not attracted much attention. Despite the limited mediated transcytosis and BBB disruption, effectively studies reporting that the SPARC pathway can be applied enhance the distribution of drugs to the brain via trans- in glioma-targeting biomimetic delivery, SPARC was cellular and paracellular pathways, respectively24,25. shown to prominently improve treatment outcome42,43. However, receptor-mediated transcytosis is strongly lim- Moreover, albumin can be modified with functional ited by the amount of receptors and their recycling26.To ligands and encapsulate various antineoplastic drugs, thus maximize BBB penetrability, BBB disruption methods, constituting an ideal and natural glioma-targeting carrier. such as focused ultrasound, which delivers drugs to the For example, menthol-modified bovine serum albumin brain by directly opening TJs, have been frequently (MeB), prepared by conjugating 8-mercaptomenthone applied27,28. However, BBB disruption is commonly with bovine serum albumin (BSA), not only induces BBB associated with severe side effects29. Thus, it is important disruption, but also penetrates the BBB directly through to find a safe and effective way for BBB opening. the pineal body pathway44. Thus, MeB can be used to During the clinical practice of traditional Chinese deliver drugs to the brain safely and effectively and allow medicine for thousands of years, some aromatic resusci- the selective accumulation of these drugs in
Load more

Recommended publications
  • Excluded Drug List
    Excluded Drug List The following drugs are excluded from coverage as they are not approved by the FDA ACTIVE-PREP KIT I (FLURBIPROFEN-CYCLOBENZAPRINE CREAM COMPOUND KIT) ­ ACTIVE-PREP KIT II (KETOPROFEN-BACLOFEN-GABAPENTIN CREAM COMPOUND KIT) ­ ACTIVE-PREP KIT III (KETOPROFEN-LIDOCAINE-GABAPENTIN CREAM COMPOUND KIT) ­ ACTIVE-PREP KIT IV (TRAMADOL-GABAPENTIN-MENTHOL-CAMPHOR CREAM COMPOUND KIT) ­ ACTIVE-PREP KIT V (ITRACONAZOLE-PHENYTOIN SODIUM CREAM CMPD KIT) ­ ADAZIN CREAM (BENZO-CAPSAICIN-LIDO-METHYL SALICYLATE CRE) ­ AFLEXERYL-LC PAD (LIDOCAINE-MENTHOL PATCH) ­ AFLEXERYL-MC PAD (CAPSAICIN-MENTHOL TOPICAL PATCH) ­ AIF #2 DRUG PREPERATION KIT (FLURBIPROFEN-GABAPENT-CYCLOBEN-LIDO-DEXAMETH CREAM COMPOUND KIT) ­ AGONEAZE (LIDOCAINE-PRILOCAINE KIT) ­ ALCORTIN A (IODOQUINOL-HYDROCORTISONE-ALOE POLYSACCHARIDE GEL) ­ ALEGENIX MIS (CAPSAICIN-MENTHOL DISK) ­ ALIVIO PAD (CAPSAICIN-MENTHOL PATCH) ­ ALODOX CONVENIENCE KIT (DOXYCYCLINE HYCLATE TAB 20 MG W/ EYELID CLEANSERS KIT) ­ ANACAINE OINT (BENZOCAINE OINT) ­ ANODYNZ MIS (CAPSAICIN-MENTHOL DISK) ­ APPFORMIN/D (METFORMIN & DIETARY MANAGEMENT CAP PACK) ­ AQUORAL (ARTIFICIAL SALIVA - AERO SOLN) ­ ATENDIA PAD (LIDOCAINE-MENTHOL PATCH) ­ ATOPICLAIR CRE (DERMATOLOGICAL PRODUCTS MISC – CREAM) ­ Page 1 of 9 Updated JANUARY 2017 Excluded Drug List AURSTAT GEL/CRE (DERMATOLOGICAL PRODUCTS MISC) ­ AVALIN-RX PAD (LIDOCAINE-MENTHOL PATCH) ­ AVENOVA SPRAY (EYELID CLEANSER-LIQUID) ­ BENSAL HP (SALICYLIC ACID & BENZOIC ACID OINT) ­ CAMPHOMEX SPRAY (CAMPHOR-HISTAMINE-MENTHOL LIQD SPRAY) ­ CAPSIDERM PAD (CAPSAICIN-MENTHOL
    [Show full text]
  • Inhibitory Effects of Monoterpenes on Human TRPA1 and the Structural Basis of Their Activity
    J Physiol Sci (2014) 64:47–57 DOI 10.1007/s12576-013-0289-0 ORIGINAL PAPER Inhibitory effects of monoterpenes on human TRPA1 and the structural basis of their activity Masayuki Takaishi • Kunitoshi Uchida • Fumitaka Fujita • Makoto Tominaga Received: 26 July 2013 / Accepted: 2 September 2013 / Published online: 12 October 2013 Ó The Author(s) 2013. This article is published with open access at Springerlink.com Abstract TRPA1, one of the transient receptor potential on these identified TRPA1 antagonists could lead to new channels, has been reported to be involved in nociception pain therapeutics. and inflammatory pain, suggesting that this molecule could be a promising target for the development of analgesic Keywords Monoterpene Á Pain relief Á TRPA1 Á agents. We screened several monoterpene analogs of Hydroxyl group camphor, which is known to inhibit human (h) TRPA1, to identify more effective naturally occurring TRPA1 antag- onists. Borneol, 2-methylisoborneol, and fenchyl alcohol Introduction exhibited higher inhibitory effects on hTRPA1 activity than either camphor or 1,8-cineole. Our results revealed Transient receptor potential (TRP) channels respond to a further that the S873, T874, and Y812 residues of hTRPA1 wide variety of sensory stimuli, including temperature, were involved in the inhibitory effects, suggesting that the nociceptive compounds, touch, osmolarity, and phero- hydroxyl group in the six-membered ring of the inhibitors mones [1–3]. TRPA1, one of the TRP channels, functions may be interacting with these amino acids. Further research as a receptor that responds to noxious cold temperatures and pungent compounds, including allyl isothiocyanate (AITC), a component of mustard oil [4–8].
    [Show full text]
  • Avoiding Medication Mayhem
    Avoiding Medication Mayhem Penny Miller, BSc.(Pharm.), M.A. Senior Instructor, Faculty of Pharmaceutical Sciences and Department of Family Practice, UBC Pharmacotherapeutic Consultant, Lifemark Health Chronic pain Program Disclosure I have nothing to disclose concerning possible financial or personal relationships with commercial entities that may have a direct or indirect interest in the subject matter of this presentation. Goal: Provide the clinician with practical information to support the medication management of patients with chronic pain. Learning Objectives: At the end of this session, the clinician will demonstrate improved abilities to: 1. Describe the rationale, efficacy, benefits and risks associated with non-steroidal anti-inflammatory agents, opioids, antidepressants and anticonvulsants in the treatment of chronic pain. 2. Identify appropriate combinations of medications. 3. Outline the important reasons for slow upward titrations and slow tapers off medications. 4. Discuss effective monitoring for the efficacy and side effects of drugs to meet the outcomes of increased functioning, improved sleep and reduced pain. Case of Ben 45 y.o., construction worker • Low back pain x 7 months after a fall at work • Constant throbbing ache in low back • Radiates down right buttock & thigh, at times extends to right ankle (burning, shooting, electric pain) • Pain level on good day 5/10, on bad day 8/10, average 7/10 (over past week) • Sleep 3 hours nightly interrupted 3 times. • Diagnosis: Lumbar radiculopathy (neuropathy with nerve root
    [Show full text]
  • Thymol, Menthol and Camphor from Indian Sources
    THYMOL, MENTHOL AND CAMPHOR IN INDIA : CHOPRA & MUKHERJEE 361 ' sweetmeats, in pan supari' (betel leaf) mix- Articles tures, etc. The ajowan plant has, therefore, Original been grown to a greater or lesser extent all /over India. It is particularly abundant in Bengal, Central India (Indore) and Hyderabad THYMOL, MENTHOL AND CAMPHOrf (Deccan). 7,000 to 8,000 acres of land FROM INDIAN SOURCES Nearly are under cultivation each year in the Nizam's By R. N. CHOPRA, m.a., m.d. (Cantab.) Dominions alone and similar large areas are LIEUTENANT-COLONEL, I.M.S. also stated to be under cultivation in the and the United Provinces. i and Punjab Large quantities also find their way into India through B. m.b. MUKHERJEE, (Cal.) the inland routes from Afghanistan, Baluchistan Indigenous Drugs Enquiry, I. R. F. A., Series No. 35 and Persia. It can in fact be grown in any of the Indian Peninsula and the (From the Department of Pharmacology, School of part country Tropical Medicine, Calcutta) has possibilities of being a rich source of raw material for the of Indeed Thymol, menthol and camphor are well production thymol. this source has been the known in the materia medica of western already exploited by manufacturers as will be seen from the medicine as well as in that of the foreign indigenous of seeds from India between medicine in India. Thymol has been considered quantities exported 1911 and 1918 :? important on account of its powerful antiseptic, Value of germicidal and anthelmintic properties. One T otal the quantity seed of its chief uses in recent years has been in the in cwts.
    [Show full text]
  • Determining Non-Cigarette Tobacco, Alcohol, and Substance Use
    Cohn et al. Tobacco Induced Diseases (2017) 15:5 DOI 10.1186/s12971-017-0111-5 RESEARCH Open Access Determining non-cigarette tobacco, alcohol, and substance use typologies across menthol and non-menthol smokers using latent class analysis Amy Cohn1,2*, Amanda Johnson1,JenniferPearson1,3, Shyanika Rose1, Sarah Ehlke1, Ollie Ganz1 and Raymond Niaura1,3 Abstract Background: Substance use and mental health are robustly associated with smoking and poor cessation outcomes, but not often examined in combination with menthol cigarette smoking, which is also associated with lower quit rates. This study identified classes of Black and White menthol and non-menthol cigarette smokers based on demographics, alcohol, drug, and other tobacco use behaviors. Methods: Using screening data from two studies, latent class analysis (LCA) was conducted to classify n = 1177 menthol and non-menthol cigarette smokers on demographic characteristics, heavy smoking, alcohol and drug use, desire to quit smoking, other tobacco product use, and use of psychotropic medication. Results: Three latent classes were identified that differentiated smokers on substance use, menthol cigarette smoking, and other tobacco use behavior. One class consisted primarily of young adults who used a wide array of other tobacco products, reported the highest prevalence of other drug use, and showed the lowest desire to quit smoking cigarettes in the next 6-months. Class 2 comprised primarily of Black male menthol smokers, all of whom used cigarillos in addition to cigarettes, and who displayed moderate drug use. The third class was categorized as primarily older cigarette smokers, who engaged in very little other tobacco use or drug use, but who were most likely to self-report being prescribed psychotropic medication.
    [Show full text]
  • International Olympic Committee Consensus Statement on Pain
    Consensus statement Br J Sports Med: first published as 10.1136/bjsports-2017-097884 on 21 August 2017. Downloaded from International Olympic Committee consensus statement on pain management in elite athletes Brian Hainline,1 Wayne Derman,2 Alan Vernec,3 Richard Budgett,4 Masataka Deie,5 Jiří Dvořák,6 Chris Harle,7 Stanley A Herring,8 Mike McNamee,9 Willem Meeuwisse,10 G Lorimer Moseley,11 Bade Omololu,12 John Orchard,13 Andrew Pipe,14 Babette M Pluim,15 Johan Ræder,16 Christian Siebert,17 Mike Stewart,18 Mark Stuart,19 Judith A Turner,20 Mark Ware,21 David Zideman,22 Lars Engebretsen4 ► Additional material is ABSTRact This consensus paper fulfils the IOC charge by published online only. To view Pain is a common problem among elite athletes and is addressing the multifaceted aspects of pain physi- please visit the journal online ology and pain management in elite athletes through (http:// dx. doi. org/ 10. 1136/ frequently associated with sport injury. Both pain and bjsports- 2017- 097884). injury interfere with the performance of elite athletes. the lenses of epidemiology, sports medicine, pain There are currently no evidence-based or consensus- medicine, pain psychology, pharmacology and For numbered affiliations see based guidelines for the management of pain in elite ethics. end of article. athletes. Typically, pain management consists of the provision of analgesics, rest and physical therapy. Correspondence to PREVALENCE OF USE OF PHARMACOLOGICAL Dr Brian Hainline, National More appropriately, a treatment strategy should AND NON-PHARMACOLOGICAL TREATMENTS Collegiate Athletic Association address all contributors to pain including underlying TO MANAGE PAIN IN ELITE atHLETES (NCAA), Indianapolis, Indiana pathophysiology, biomechanical abnormalities and Elite athletes commonly use prescription and over- 46206, US; bhainline@ ncaa.
    [Show full text]
  • Nonsteroidal Anti-Inflammatory Drugs (Nsaids)
    Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Therapeutic Class Review (TCR) June 17, 2020 No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopying, recording, digital scanning, or via any information storage or retrieval system without the express written consent of Magellan Rx Management. All requests for permission should be mailed to: Magellan Rx Management Attention: Legal Department 6950 Columbia Gateway Drive Columbia, Maryland 21046 The materials contained herein represent the opinions of the collective authors and editors and should not be construed to be the official representation of any professional organization or group, any state Pharmacy and Therapeutics committee, any state Medicaid Agency, or any other clinical committee. This material is not intended to be relied upon as medical advice for specific medical cases and nothing contained herein should be relied upon by any patient, medical professional or layperson seeking information about a specific course of treatment for a specific medical condition. All readers of this material are responsible for independently obtaining medical advice and guidance from their own physician and/or other medical professional in regard to the best course of treatment for their specific medical condition. This publication, inclusive of all forms contained herein, is intended to be educational in nature and is intended to be used for informational purposes only. Send comments and suggestions to [email protected].
    [Show full text]
  • ANTISEPTIC MOUTH RINSE- Eucalyptol, Menthol, Methyl
    ANTISEPTIC MOUTH RINSE- eucalyptol, menthol, methyl salicylate, thymol mouthwash CVS Pharmacy, Inc Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies. ---------- CVS 318.003 - 318AI Active ingredients Eucalyptol 0.092% Menthol 0.042% Methyl salicylate 0.060% Thymol 0.064% Purpose Antigingivitis, Antiplaque Use helps control plaque that leads to gingivitis Warnings For this product Do not use If you have painful or swollen gums, pus from the gum line, loose teeth or increased spacing between the teeth. See your dentist immediately. These may be signs of periodontitis, a serious form of gum disease. Stop use and ask a dentist gingivitis, bleeding, or redness persists for more than 2 weeks Keep out of reach of chrildren If more than used for rinsing is accidentally swallowed, get medical help or contact a Poison Control Center right away. Directions adults and children 12 years of age and older - vigorously swish 20 mL (2/3 FL OZ or 4 teaspoonfuls) between teeth twice a day for 30 seconds then spit out; do not swallow children under 12 years of age - consult a dentist or doctor this rinse is not intended to replace brushing or flossing Other information cold weather may cloud this product. Its antiseptic properties are not affected. Store at room temperature (59°-77°F). Inactive ingredients water, alcohol 26.9%, benzoic acid, poloxamer 407, sodium benzoate, caramel Disclaimer This product is manufactued or distributed by Johnson & Johnson Healthcare Products, distributor of Original Listerine Antiseptic Mouthwash Adverse reactions Distributed by: CVS Pharmacy, Inc.
    [Show full text]
  • Language Arts. INSTITUTION Valencia Community Coll., Orlando, Fla
    DOCUMENT RESUME ED 337 121 HE 024 965 TITLE Infusing Alcohol and Drug Prevention with Existing Classroom Study Units: Language Arts. INSTITUTION Valencia Community Coll., Orlando, Fla. SPONS AGENCY Orange County Public Schools, Orlando, Fla. PUB DATE Jul 91 NOTE 133p.; This report is part of a collection of programs, policies and curricula developed by members of the Network of Colleges and Universities Committed to the Elimination of Drug and Alcohol Education, Office of Educational Research and Improvement in response to the 1989 Drug Free Schools and Communities Act. For related documents, see HE 024 963-969. PUB TYPE Guides - Classroom Use - Instructional Materials (For Learner) (051)-- Guides - Classroom Use - Teaching Guides (For Teacher) (052) EDRS PRICE MF01/PC06 Plus Postage. DESCRIPTORS Alcohol Abuse; Drug Abuse; *Drug Education; *English Curriculum; Grade 7; Nigher Education; Junior High Schools; *Language Arts; Lesson Plans; Middle Schools; Policy Formation; *Prevention IDENTIFIERS Active Learning; *Deug Infusion Project; *Network for Drug Free Colleges ABSTRACT This curriculum module, one of seven in Infusion Project, offers information and lessons on druguse prevention for integration into an existing seventh-grade middle schoollanguage arts curriculum. The module, based ona type of interactive learning called infusion learning, contains 18 lessons each providing objectives, a list of resource materials, suggestedstudent activities, suggestions for additional classroomor out-of-class activities, and teacher tips. Many lessonscome with one or more work sheets for reproduction. The lesson topicsare: Listening Skills, Vocabulary (3), Writing (8), Grammar (5), and LibrarySkills. Also included is "Just the Facts," a set of information unitsfor teachers on alcohol, amphetamines, barbiturates, children of alcoholics, cocaine, designer drugs, driving under the influence,eating disorders, inhalants, lysergic acid diethylamide, marijuana, nutrition, opiates, phencyclidine (PCP), steroidsand tobacco.
    [Show full text]
  • Thymol, Menthol and Eucalyptol As Agents for Microbiological Control in the Oral Cavity: a Scoping Review
    Rev. Colomb. Cienc. Quím. Farm., Vol. 49(1), 44-69, 2020 www.farmacia.unal.edu.co Review article / http://dx.doi.org/10.15446/rcciquifa.v49n1.87006 Thymol, menthol and eucalyptol as agents for microbiological control in the oral cavity: A scoping review María Cecilia Martínez-Pabón1, Mailen Ortega-Cuadros2* School of Dentistry, Universidad de Antioquia, Medellín, Colombia. 1E-mail: [email protected]; ORCID: 0000-0002-8115-3089 2E-mail: [email protected]; ORCID: 0000-0002-4977-1709 Received: September 19, 2019 Accepted: April 3, 2020 Summary Dental plaque is a complex environment that maintains a balance with certain micro- bial communities; however, this microhabitat can be disturbed by some endogenous species causing disease. An exploratory systematic review was carried out using the PubMed, Scopus, Lilacs, and Science Direct databases, identifying that the thymol, menthol, and eucalyptol compounds present varying antimicrobial activity, intra- and interspecies discordance, and a strong antimicrobial intensity on Aggregatibacter actinomycetemcomitans, Candida albicans, Candida dubliniensis, Enterococcus faecalis, Escherichia coli, Lactobacillus plantarum, and Streptococcus mutans, indicating that these phytochemicals can be considered broad-spectrum antimicrobial substances, with an effect on microorganisms linked to oral diseases. Key words: Oral health, terpenes, phytochemicals. 44 Thymol, menthol and eucalyptol for microbiological control in the oral cavity Resumen Timol, mentol y eucaliptol como agentes para el
    [Show full text]
  • Method for Preparing a Stabilised Menthol Emulsion
    (19) & (11) EP 2 311 444 A1 (12) EUROPEAN PATENT APPLICATION (43) Date of publication: (51) Int Cl.: 20.04.2011 Bulletin 2011/16 A61K 31/045 (2006.01) A61K 49/00 (2006.01) A61K 9/107 (2006.01) A61K 47/10 (2006.01) (2006.01) (2006.01) (21) Application number: 11151652.2 A61K 47/26 A61K 47/34 A61K 47/02 (2006.01) A61K 47/44 (2006.01) (22) Date of filing: 28.06.2004 (84) Designated Contracting States: • Kataoka, Yosuke AT BE BG CH CY CZ DE DK EE ES FI FR GB GR Osaka Osaka 598-8558 (JP) HU IE IT LI LU MC NL PL PT RO SE SI SK TR • Isoda, Takako Osaka Osaka 598-8558 (JP) (30) Priority: 30.06.2003 JP 2003186493 (74) Representative: von Kreisler Selting Werner (62) Document number(s) of the earlier application(s) in Deichmannhaus am Dom accordance with Art. 76 EPC: Bahnhofsvorplatz 1 04746565.3 / 1 640 022 50667 Köln (DE) (71) Applicant: Nihon Pharmaceutical Co., Ltd. Remarks: Tokyo 101-0031 (JP) This application was filed on 21-01-2011 as a divisional application to the application mentioned (72) Inventors: under INID code 62. • Hamawaki, Tomonori Osaka Osaka 598-8558 (JP) (54) Method for preparing a stabilised menthol emulsion (57) It is known that L- menthol controls smooth mus- for inhibiting smooth muscle contraction or a peristaltic cle contraction. In order to use L-menthol in practice as contraction in a digestive tract containing a L-menthol a digestive tract contraction inhibiting agent in digestive emulsion having an average particle size of less than tract endoscopy, it is required to devise means of giving 100nm.
    [Show full text]
  • Electronical Supplementary Information Phenolic Hydrogen
    Electronic Supplementary Material (ESI) for ChemComm. This journal is © The Royal Society of Chemistry 2019 Electronical Supplementary Information Phenolic Hydrogen Bond Donors as the Key to the Formation of Non-Ionic Deep Eutectic Solvents: The Quest for Type V DES Dinis O. Abranches, a Mónia A. R. Martins, a,b,c Liliana P. Silva, a Nicolas Schaeffer, a Simão P. Pinhob,c and João A. P. Coutinho*, a a CICECO – Aveiro Institute of Materials, Department of Chemistry, University of Aveiro, 3810- 193 Aveiro, Portugal b Associate Laboratory LSRE-LCM, Department of Chemical and Biological Technology, Polytechnic Institute of Bragança, 5300-253 Bragança, Portugal c Mountain Research Center – CIMO, Polytechnic Institute of Bragança, 5301-855 Bragança, Portugal * Corresponding author e-mail address: [email protected] (João A. P. Coutinho) Number of Pages: 8 Number of Tables: 2 Number of Figures: 5 1 | Page Experimental Details The SLE phase diagram of the mixture menthol + thymol was determined by Differential Scanning Calorimetry (DSC). First, mixtures were prepared in the full range of compositions using an analytic balance Mettler Toledo XP205. Samples were heated under stirring until a homogenous liquid was formed and stirred in the liquid state for 30 minutes. After cooling at room temperature, samples of 2 – 5 mg were hermetically sealed in aluminium pans and weighed in a micro-analytical balance AD6 (PerkinElmer, precision = 0.002 mg). A Hitachi DSC7000X working at atmospheric pressure was used to acquire the thermal events at 5 K/min and 2 K/min for cooling and heating, respectively. The equipment was previously calibrated with several standards with weight fraction purities higher than 99%.
    [Show full text]